News and Announcements
Universal Biosensors Business Update; Fast Revenue Growth, Unique Patent Protected Technology & New Product Development
- Published June 21, 2016 12:30PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
21st June 2016, ASX Announcement
UBI: Investment Highlights:
- Targeting the large and growing Point-of-Care Diagnostics market
- Fast growth in revenues based on sale of disposable test strips
- Validating the technology through partnering deals with LifeScan and Siemens
- Unique patent protected technology with low cost manufacturing
- Driving growth beyond the existing product platform via new product development
Strong revenue performance with record Quarterly Service Fees achieved
- Blood glucose monitoring : QSF generated from OneTouch® Verio® were $4.9m in Q1’FY16 (up 68% compared to pcp)
- Blood coagulation monitoring : Xprecia Stride™ revenues were $183k in Q1’FY16 (up 154% compared to pcp)
- Total FY15 revenues improved 76% compared to pcp to $16.8m
To view the full announcement, please click on the button below.